Methods for myocardial imaging in patients having a history of pulmonary disease
作者： Brent Blackburn , Hsiao D. Lieu , Luiz Belardinelli
DOI:
关键词:
摘要: The present application discloses methods for myocardial imaging in human patients having a history of pulmonary disease such as asthma, bronchospasm, chronic obstructive disease, fibrosis, inflammation, or hypertension, comprising administrating doses one more A 2A adenosine receptor agonists to mammal undergoing and detecting and/or diagnosing dysfunction.
google.de 参考文章(62)
Julius Diamond, Xanthine compounds and method of treating bronchospastic and allergic diseases ,(1976)
David Shealy, Don Edgar Griswold, George A. Heavner, Li Li, Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses ,(2003)
Venkata P. Palle, Elfatih O. Elzein, Jeff A. Zablocki, 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists ,(2000)
Richard J. Barrett, Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm ,(2006)
Tim Marquart, Elfatih Elzein, Prabha N. Ibrahim, Jeff Zablocki, Venkata P. Palle, Brent K. Blackburn, Aralkyl substituted piperazine compounds ,(2001)
James R. Lawter, John M. Pawelchak, Enchancers for the transdermal flux of nivadipine ,(1987)
Jeri D. Wright, Brian L. Barclay, Jerry D. Childers, Patrick S. L. Wong, Dosage form for administering nilvadipine for treating cardiovascular symptoms ,(1988)
Per Gunnar Kjellin, Carl Goran August Persson, Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives ,(1979)
James R. Lawter, John M. Pawelchak, Transdermal delivery of pharmaceuticals ,(1988)